Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus
- 9 February 2009
- journal article
- research article
- Published by Elsevier BV in Analytica Chimica Acta
- Vol. 633 (2), 257-262
- https://doi.org/10.1016/j.aca.2008.11.058
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Study of traditional Chinese medicine volatile oils from different geographical origins by comprehensive two-dimensional gas chromatography–time-of-flight mass spectrometry (GC×GC–TOFMS) in combination with multivariate analysisJournal of Pharmaceutical and Biomedical Analysis, 2007
- Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS‐LDAFEBS Letters, 2006
- Comprehensive Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry Analysis of Metabolites in Fermenting and Respiring Yeast CellsAnalytical Chemistry, 2006
- Algorithm for locating analytes of interest based on mass spectral similarity in GC × GC–TOF-MS data: analysis of metabolites in human infant urineJournal of Chromatography A, 2004
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- Global and societal implications of the diabetes epidemicNature, 2001
- Cellular mechanisms of insulin resistanceJCI Insight, 2000
- Mechanism of free fatty acid-induced insulin resistance in humans.JCI Insight, 1996
- Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.JCI Insight, 1994
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSThe Lancet, 1963